Related Experiment Video
Updated: Jan 3, 2026
Activation and Measurement of NLRP3 Inflammasome Activity Using IL-1β in Human Monocyte-derived Dendritic Cells
Published on: May 22, 2014
MicroRNA-223-3p modulates dendritic cell function and ameliorates experimental autoimmune myocarditis by targeting
Liangqi Chen1, Xinyu Hou1, Maomao Zhang1
1Department of Cardiology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China; The Key Laboratory of Myocardial Ischemia, Harbin Medical University, Ministry of Education, Harbin, China.
Abstract:
Autoimmune myocarditis is a cause of dilated cardiomyopathy and heart failure. MicroRNAs regulate many immune processes, but their role in aberrant inflammation during autoimmune myocarditis remains unclear. In this study, we investigated the role of miR-223-3p in experimental autoimmune myocarditis (EAM). We found that miR-223-3p expression was significantly lower in EAM mice than that in normal mice. miR-223-3p inhibited NLRP3 inflammasome expression, promoting the polarization of dendritic cells (DCs) towards a tolerogenic DC phenotype. miR-223-3p effectively induced regulatory T cell (Treg) generation by inhibiting the function of antigen-presenting DCs. Transfer of miR-223-3p-overexpressing DCs protected mice against the development of EAM. Our findings suggest that miR-223-3p is involved in the induction of the tolerogenic DC phenotype and regulates tolerance in autoimmune myocarditis.
Insights
MicroRNA-223-3p is crucial in regulating autoimmune myocarditis by promoting immune tolerance. Lower levels of this microRNA in disease models highlight its potential therapeutic role in heart failure.
Area of Science:
- Immunology
- Cardiology
- Molecular Biology
Background:
- Autoimmune myocarditis can lead to dilated cardiomyopathy and heart failure.
- The specific role of microRNAs in the inflammatory processes of autoimmune myocarditis is not fully understood.
Purpose of the Study:
- To investigate the function of miR-223-3p in experimental autoimmune myocarditis (EAM).
- To explore the potential of miR-223-3p as a therapeutic target for autoimmune heart conditions.
Main Methods:
- Assessed miR-223-3p expression levels in EAM mice.
- Examined the effect of miR-223-3p on NLRP3 inflammasome and dendritic cell (DC) polarization.
- Investigated the impact of miR-223-3p on regulatory T cell (Treg) generation.
- Evaluated the therapeutic effect of transferring miR-223-3p-overexpressing DCs in EAM mice.
Main Results:
- miR-223-3p expression was significantly reduced in EAM mice compared to controls.
- miR-223-3p suppressed NLRP3 inflammasome and promoted a tolerogenic DC phenotype.
- miR-223-3p facilitated Treg generation by modulating antigen-presenting DC function.
- Transfer of miR-223-3p-overexpressing DCs conferred protection against EAM development.
Conclusions:
- miR-223-3p plays a key role in inducing a tolerogenic DC phenotype.
- This microRNA regulates immune tolerance in the context of autoimmune myocarditis.
- miR-223-3p represents a potential therapeutic strategy for autoimmune myocarditis and related heart failure.
